RELISA®

Relisa header n1
Relisa header
Relisa header n1

Robust ELISA performance is judged by not only accuracy, but consistency. Our reliable ELISA (RELISA) product line is superior in both.

Our RELISA® ANA screen has been shown to be quite effective at detecting clinically significant autoantibodies to nuclear antigens including: Sm/RNP, SS-A/Ro, SS-B/La, dsDNA, Scl-70, and others. These are autoantibodies often seen in patients with SLE or other systemic rheumatic diseases.

The RELISA® ENA Single Well Screening Kit is designed to screen patient samples for six of the most common autoantibodies. Each microtiter well is coated with Sm, RNP, SS-A, SS-B, Scl-70, and Jo-1 autoantigens. This allows the laboratory to cost-effectively screen out the ENA negative patient samples prior to determining the ENA specificity on any of the company’s other RELISA® ENA Test Systems.
The RELISA® ENA Multiparameter Kit is designed for testing patient samples for six of the most common autoantibodies (SSA/Ro, SSB/La, Sm, Sm/RNP, Scl-70, and Jo-1). This kit features a unique quality control system. The built-in RPC (RELISA® Procedure Check) well in each strip gives the laboratory maximum flexibility in determining their quality control procedures.
Our RELISA® MPO and PR3 Antibody Test Kits are a convenient method for confirmation of MPO- or PR3-ANCA autoantibodies.

This isotype-specific RELISA® Cardiolipin Kit is designed to determine the in- dividual concentrations of IgG and IgM anti-cardiolipin antibodies in patient samples.

Not FDA cleared​

Several assays are available for the detection of anti-dsDNA antibodies. The most commonly used methods include indirect immunofluorescence, radioimmunoassay, counterimmunoelectrophoresis, and immunodiffusion. The Immuno Concepts RELISA® anti-dsDNA test system is an enzyme immunoassay (EIA) method that detects serum antibodies to dsDNA.